HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

lanreotide (Somatuline)

somatostatin analogue that suppresses GH/IGF-I hypersecretion in acromegaly patients and used to manage neuroendocrine tumours; do not confuse with BIM 23014 C
Also Known As:
Somatuline; 188Re-lanreotide; 2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide; 3-(2-naphthyl)-D-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2; 3-(2-naphthyl)alanyl-cystinyl-tyrosyl-tryptophyl-lysyl-valyl-cystinyl-threonine amide; BIM 23014; BIM 23014 C; BIM 23014C; BIM-23014; BIM-23014 C; D-Nal-Cys-Tyr-Trp-Lys-Val-Cys-Thr-NH2; DC 13-116; DC-13-116; DC13-116; L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide; Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)-Thr-NH2; Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2; Somatulin; Somatulina; angiopeptin; lanreotide acetate; lanreotide-SR; naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide; naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2; L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
Networked: 654 relevant articles (130 outcomes, 168 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Colao, Annamaria: 23 articles (06/2020 - 03/2002)
2. Pivonello, Rosario: 12 articles (06/2016 - 04/2003)
3. Mirakhur, Beloo: 11 articles (01/2021 - 01/2017)
4. Drenth, Joost P H: 10 articles (11/2021 - 11/2009)
5. Lombardi, Gaetano: 9 articles (04/2011 - 03/2002)
6. Melmed, Shlomo: 8 articles (01/2022 - 01/2002)
7. Houchard, Aude: 8 articles (07/2021 - 04/2016)
8. Ruszniewski, Philippe: 8 articles (01/2019 - 01/2004)
9. Colao, A: 8 articles (06/2010 - 01/2000)
10. Lombardi, G: 8 articles (03/2009 - 01/2000)

Related Diseases

1. Acromegaly
2. Neoplasms (Cancer)
3. Neuroendocrine Tumors (Neuroendocrine Tumor)
4. Carcinoid Tumor (Carcinoid)
5. Autosomal Dominant Polycystic Kidney (ADPKD)

Related Drugs and Biologics

1. Octreotide (Sandostatin)
2. Somatostatin (Somatotropin Release-Inhibiting Factor)
3. lanreotide (Somatuline)
4. Insulin-Like Growth Factor I (IGF-1)
5. Somatostatin Receptors (Somatostatin Receptor)
6. pasireotide
7. Delayed-Action Preparations
8. Peptides (Polypeptides)
9. pegvisomant
10. vapreotide

Related Therapies and Procedures

1. Therapeutics
2. Injections
3. Drug Therapy (Chemotherapy)
4. Subcutaneous Injections
5. Ligation